Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1475-2840

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D ; volume:18 ; number:1 ; day:25 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (25.2.2019), 1-12, 12.2019

Creator: La Sala, Lucia
Mrakic-Sposta, Simona
Tagliabue, Elena
Prattichizzo, Francesco
Micheloni, Stefano
Sangalli, Elena
Specchia, Claudia
Uccellatore, Anna Chiara
Lupini, Silvia
Spinetti, Gaia
de Candia, Paola
Ceriello, Antonio

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12933-019-0824-2

URN: urn:nbn:de:101:1-2019032320105244994179

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show object at data provider

Associated

La Sala, Lucia
Mrakic-Sposta, Simona
Tagliabue, Elena
Prattichizzo, Francesco
Micheloni, Stefano
Sangalli, Elena
Specchia, Claudia
Uccellatore, Anna Chiara
Lupini, Silvia
Spinetti, Gaia
de Candia, Paola
Ceriello, Antonio
SpringerLink (Online service)

Other Objects (12)

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Age-associated network controllability changes in first episode drug-naïve schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The Cerebellum in Drug-naive Children with Tourette Syndrome and Obsessive–Compulsive Disorder

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

The genetic determinants of language network dysconnectivity in drug-naïve early stage schizophrenia

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Altered dynamic functional and effective connectivity in drug-naive children with Tourette syndrome

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Transcriptional patterns of amygdala functional connectivity in first-episode, drug-naïve major depressive disorder

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.